NCT06538844 - Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy | Biotech Hunter

Enrollment

134

Participants

Timeline

Start Date

August 10, 2024

Primary Completion Date

December 20, 2024

Study Completion Date

March 15, 2025

Conditions

Acute Ischemic Stroke

Interventions

DRUG

Intravenous infusion of human albumin

Administer 0.5g/kg of 25% human albumin intravenously as soon as possible within 60 minutes after randomization. And administer 0.5g/kg of 25% ALB intravenously every day on the second, third, and fourth days after randomization.

DRUG

Saline

Equivalent volume of isotonic saline control

Trial Locations (8)

Unknown

Maanshan People's Hospital, Ma’anshan

Suzhou Municipal Hospital of Anhui Province, Suzhou

Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang

Nanyang Central Hospital, Nanyang

First People's Hospital of Zhengzhou City, Zhengzhou

Xihua County People's Hospital, Zhoukou

Northern Jiangsu People's Hospita!, Yangzhou

Liaocheng Third People's Hospital, Liaocheng

All Listed Sponsors

collaborator

Xuanwu Hospital, Beijing

OTHER

lead

Capital Medical University

OTHER